Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.7K Sell
480
-15
-3% -$1.76K 0.02% 120
2026
Q1
$59.5K Sell
495
-14
-3% -$1.62K 0.03% 104
2025
Q4
$53.6K Buy
509
+140
+38% +$13.1K 0.02% 109
2025
Q3
$31K Buy
369
+27
+8% +$2.22K 0.01% 152
2025
Q2
$27.1K Buy
+342
New +$27.2K 0.01% 141

Other funds holding MRK

Kilter Group's MRK Position: Q2 2026 in Review

Kilter Group reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $1.76K and leaving 480 shares worth $61.7K. The position accounts for 0.02% of the portfolio, ranked #120.

Kilter Group first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kilter Group held 480 shares of Merck worth $61.7K as of Q2 2026.
  • Kilter Group sold 15 Merck shares in Q2 2026, an estimated $1.76K.
  • Merck made up 0.02% of Kilter Group's portfolio in Q2 2026, its #120 holding.
  • Kilter Group first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.